Synklino
15+ years’ in life science and the biopharmaceutical industry. Highly experienced with development, operations and CMC and previous Senior Director at Symphogen.
Synklino
1 followers
Synklino is a developer of a CMV-specific immunotoxin intended to eradicate the cytomegalovirus infection.